The global specimen validity testing market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 6% during the forecast period (2022-2029).
The test method used to determine if a urine specimen is abnormal or tampered with is known as Specimen Validity Testing (SVT), also known as adulteration testing.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/specimen-validity-testing-market
The factors expected to drive the growth of the global specimen validity testing market are the growing need for drug screening and the increasing number of drug abuse cases.
The growing demand for drug screening is expected to drive market growth in the forecast period
Heroin, cocaine, marijuana, hallucinogens, inhalants, and nonmedical use of prescription psychotherapeutics are all examples of illegal drug use (stimulants, tranquilizers, and painkillers). According to the National Center for Drug Abuse Statistics, over a year, 10.1 million Americans, or 3.7 percent, misuse opioids at least once. An opioid use disorder affects 1.6 million people or 15.8% of the population. Prescription pain relievers are used by 9.7 million opioid abusers or 96.6 per cent. Urine drug screening is a clinical method that can improve hospital safety, track patient compliance with treatment, diagnose drug abuse (illicit and legal), and prescription drug diversion.
Urine drug screening is a clinical tool for improving workplace safety, monitoring patient medication compliance, and detecting drug (illicit and prescription) abuse and prescription medication diversion. Because drug testing has personal, occupational, and legal ramifications, pain specialists and primary care physicians must be confident in their ability to interpret urine drug assay results to respond appropriately to improve clinical outcomes. Many companies are offering specimen validity testing. For instance, to help determine if a valid urine sample is being tested, Siemens Healthineers offers five specimen validity tests. The Atellica CH Analyzer, ADVIA Chemistry Systems, and Viva Drug Testing Systems have tests. Hence, with the growing need for drug screening, the global specimen validity testing market is expected to grow in the forecast period.
By Product & Services
- Laboratory Testing
- Rapid/POC Testing
By End User
- Drug Screening Laboratories
- Pain Management Centers
With mergers, acquisitions, and product launches, the global specimen validity testing market is moderately competitive. Some of the key players in the market are Alere Inc., Thermo Fisher Scientific, LabCorp, American Bio Medica Corporation, Premier Biotech, Inc., Sciteck, Abbott Laboratories, Quest Laboratory Testing.
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.